Mark Lust

552 total citations
29 papers, 326 citations indexed

About

Mark Lust is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Mark Lust has authored 29 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 18 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Mark Lust's work include Inflammatory Bowel Disease (19 papers), Microscopic Colitis (12 papers) and Autoimmune and Inflammatory Disorders (9 papers). Mark Lust is often cited by papers focused on Inflammatory Bowel Disease (19 papers), Microscopic Colitis (12 papers) and Autoimmune and Inflammatory Disorders (9 papers). Mark Lust collaborates with scholars based in Australia, United Kingdom and Serbia. Mark Lust's co-authors include Michael A. Kamm, David Ong, Simon Travis, Emily K. Wright, Jelena Djordjević, William Connell, Emma Culver, Barbara Braden, John Halliday and Roger W. Chapman and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and Trends in Molecular Medicine.

In The Last Decade

Mark Lust

28 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Lust Australia 12 198 158 131 59 50 29 326
Farhad Peerani Canada 8 344 1.7× 306 1.9× 166 1.3× 94 1.6× 67 1.3× 42 489
Aurada Cholapranee United States 3 238 1.2× 196 1.2× 76 0.6× 31 0.5× 70 1.4× 6 331
Rishi Bolia India 13 66 0.3× 125 0.8× 187 1.4× 85 1.4× 32 0.6× 63 361
Klaus Theede Denmark 11 363 1.8× 320 2.0× 182 1.4× 31 0.5× 61 1.2× 27 498
Aurora Bortoli Italy 10 241 1.2× 208 1.3× 213 1.6× 26 0.4× 82 1.6× 18 488
Sameer Al Awadhi United Arab Emirates 11 155 0.8× 118 0.7× 134 1.0× 12 0.2× 42 0.8× 26 305
Peter Thielsen Denmark 8 92 0.5× 113 0.7× 66 0.5× 57 1.0× 53 1.1× 17 274
Marianne Kajbæk Vester-Andersen Denmark 15 407 2.1× 358 2.3× 193 1.5× 41 0.7× 47 0.9× 19 533
Cristina Alba Spain 10 326 1.6× 238 1.5× 104 0.8× 23 0.4× 81 1.6× 22 502
Zachary Zator United States 7 165 0.8× 235 1.5× 105 0.8× 32 0.5× 28 0.6× 10 307

Countries citing papers authored by Mark Lust

Since Specialization
Citations

This map shows the geographic impact of Mark Lust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lust more than expected).

Fields of papers citing papers by Mark Lust

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Lust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lust. The network helps show where Mark Lust may publish in the future.

Co-authorship network of co-authors of Mark Lust

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Lust. A scholar is included among the top collaborators of Mark Lust based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Lust. Mark Lust is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flanagan, Emma, Emily K. Wright, Winita Hardikar, et al.. (2024). Thrombocytosis and Transaminitis in Infants Born to Women With Inflammatory Bowel Disease Is Associated With Exposure to Maternal Inflammation In Utero. Inflammatory Bowel Diseases. 30(12). 2323–2334. 4 indexed citations
2.
Basnayake, Chamara, Emily K. Wright, Mark Lust, et al.. (2023). Risk factors for malignancy and serious infection in patients with inflammatory bowel disease: a retrospective analysis. Internal Medicine Journal. 54(3). 446–454. 1 indexed citations
3.
Vogrin, Sara, Chamara Basnayake, William Connell, et al.. (2023). Relationship Between Serum Ustekinumab Trough Concentration and Clinical and Biochemical Disease Activity: A Real-World Study in Adult Patients with Crohn’s Disease. European Journal of Drug Metabolism and Pharmacokinetics. 48(3). 271–279. 3 indexed citations
4.
Yu, Natalie, Stéphanie Fry, Alyson L Ross, et al.. (2023). Outcomes of a Comprehensive Specialist Inflammatory Bowel Disease Nursing Service. Inflammatory Bowel Diseases. 30(6). 960–969. 3 indexed citations
5.
Basnayake, Chamara, William Connell, Emily K. Wright, et al.. (2022). Clinical outcomes amongst elderly patients with inflammatory bowel disease. Internal Medicine Journal. 53(10). 1866–1874. 2 indexed citations
6.
Fehily, Sasha R., et al.. (2022). Isolated esophageal IgG4-related disease presenting with progressive dysphagia and weight loss in a middle-aged man. Clinical Journal of Gastroenterology. 15(3). 526–530. 1 indexed citations
7.
Wright, Emily K., Jacinta A. Holmes, Alexander Thompson, et al.. (2021). Telehealth model of care for outpatient inflammatory bowel disease care in the setting of the COVID‐19 pandemic. Internal Medicine Journal. 51(7). 1038–1042. 20 indexed citations
8.
Basnayake, Chamara, William Connell, Nik S. Ding, et al.. (2021). Systematic review: efficacy of escalated maintenance anti‐tumour necrosis factor therapy in Crohn's disease. Alimentary Pharmacology & Therapeutics. 54(3). 249–266. 11 indexed citations
9.
Wright, Emily K., Bronte A. Holt, Tom Sutherland, et al.. (2021). P300 Crohn’s Disease Strictures Respond to Drug Treatment and Treat-to-Target Intense Combination Therapy is More Effective than Standard Anti-TNF Therapy. The STRIDENT Randomised Controlled Trial. Journal of Crohn s and Colitis. 15(Supplement_1). S328–S330. 2 indexed citations
10.
Wright, Emily K., Bronte A. Holt, Amy L. Hamilton, et al.. (2021). Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial. ˜The œLancet. Gastroenterology & hepatology. 7(4). 318–331. 37 indexed citations
11.
Lee, Tanya, Michael A. Kamm, Sally Bell, et al.. (2020). Long‐term outcomes of perianal fistulizing Crohn's disease in the biologic era. JGH Open. 5(2). 235–241. 6 indexed citations
12.
Connell, William, Jingjing Ding, Ola Niewiadomski, et al.. (2020). Virtually perfect? High patient satisfaction and reduced work absenteeism using a telehealth model of inflammatory bowel disease care during the coronavirus pandemic. Journal of Gastroenterology and Hepatology. 35. 114–114. 1 indexed citations
13.
Wu, Kaichun, Sally Bell, MA Kamm, et al.. (2018). Clinical outcomes and management of patients with concomitant primary sclerosing cholangitis and inflammatory bowel disease. Journal of Gastroenterology and Hepatology. 33. 1 indexed citations
14.
Goldberg, Rimma, Gregory Moore, Philip Marsh, et al.. (2015). Thiopurine metabolite testing in inflammatory bowel disease. Journal of Gastroenterology and Hepatology. 31(3). 553–560. 16 indexed citations
15.
Halliday, John, Jelena Djordjević, Mark Lust, et al.. (2011). A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease. Journal of Crohn s and Colitis. 6(2). 174–181. 60 indexed citations
16.
Djordjevic, Jelena, et al.. (2011). 1294 PSC-CROHNS DISEASE: CHARACTERISATION OF THIS PATIENT GROUP FOR THE FIRST TIME REVEALS A UNIQUE CLINICAL PHENOTYPE. Journal of Hepatology. 54. S510–S510. 1 indexed citations
17.
Cruz, Peter De, Mark Lust, Nicholas Trost, et al.. (2008). Cerebral venous thrombosis associated with ulcerative colitis. Internal Medicine Journal. 38(11). 865–867. 13 indexed citations
18.
Moore, Gregory, Steven J Brown, Adam Winterhalter, et al.. (2008). Glycosylation changes in hFUT1 transgenic mice increase TCR signaling and apoptosis resulting in thymocyte maturation arrest. Molecular Immunology. 45(8). 2401–2410. 16 indexed citations
19.
Lust, Mark, Marisa Vulcano, & Silvio Danese. (2008). The protein C pathway in inflammatory bowel disease: the missing link between inflammation and coagulation. Trends in Molecular Medicine. 14(6). 237–244. 15 indexed citations
20.
Lust, Mark, et al.. (2006). Measurement of faecal fat excretion: an evaluation of attitudes and practices of Australian gastroenterologists. Internal Medicine Journal. 36(2). 77–85. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Farhad Peerani Breakdown of academic impact, for papers by Aurada Cholapranee Breakdown of academic impact, for papers by Rishi Bolia Breakdown of academic impact, for papers by Klaus Theede Breakdown of academic impact, for papers by Aurora Bortoli Breakdown of academic impact, for papers by Sameer Al Awadhi Breakdown of academic impact, for papers by Peter Thielsen Breakdown of academic impact, for papers by Marianne Kajbæk Vester-Andersen Breakdown of academic impact, for papers by Cristina Alba Breakdown of academic impact, for papers by Zachary Zator
Rankless by CCL
2026